Edap Tms (FOCL) Depreciation & Amortization (CF) (2025 - 2026)
Edap Tms' (FOCL) quarterly Depreciation & Amortization (CF) came in at $896000.0 in Q1 2026, up 18.99% YoY from $753000.0 in Q1 2025, and up 18.99% on a QoQ basis from $753000.0 in Q1 2025.
Edap Tms (FOCL) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
Edap Tms (FOCL) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $896000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 18.99% year-over-year to $896000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $896000.0 (up 18.99% YoY) and the FY2025 annual result came in at $3.4 million, up 22.69% from the prior year.
- Depreciation & Amortization (CF) climbed to $896000.0 in Q1 2026, from $753000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $896000.0 in Q1 2026 to a low of $753000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 241.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 84.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 1.01 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 65.70 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 347,533.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 896,000.00 |
| Mar 31, 2026 | 896,000.00 |
| Mar 31, 2025 | 753,000.00 |
| Mar 31, 2025 | 753,000.00 |